Find trials
Consejos para buscar

Collection of Primary Retroperitoneal Sarcoma Data, Radiological, and Pathological Material for the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

Overview

Información sobre este estudio

The purpose of this study is to prospectively collect standardized clinical data and radiological and pathological material from primary retroperitoneal sarcomas RPS patients treated with surgery at reference centers. Patient outcome will be evaluated in terms of overall survival (OS), disease-free survival (DFS), crude cumulative incidence (CCI) of local recurrence (LR) and distant metastasis (DM).

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Primary RPS operated on in the participating center.
  • Primary RPS who undergo incomplete resection at another hospital and therefore candidate to completion surgery of persistent primary disease in the participating center.
  • Primary RPS candidate to neoadjuvant treatment in the participating center and not receiving surgery for whichever reason.
  • Age>18 years at the time of the first treatment (pediatric patients can not be included).
  • Histological confirmed diagnosis according to the WHO criteria done on biopsy or surgical specimen by dedicated sarcoma pathologist.
  • Radiological examinations performed (contrast enhanced abdominal CT scan and/or MRI) prior to surgical resection.
  • Signed informed consent form.
  • Adequate compliance of the patients to the plan of follow-up.

Exclusion Criteria:

  • Age < 18 years.
  • Recurrent tumor.
  • Benign retroperitoneal tumors.
  • Serious psychiatric disease that precludes informed consent or limits compliance.
  • Impossibility to ensure adequate follow-up.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/16/23. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Sanjay Bagaria, M.D.

Abierto para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20560430

Mayo Clinic Footer